These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Blockade of the in vitro effects of testosterone and erythropoietin on Cfu-E and Bfu-E proliferation by pretreatment of the donor rats with cyproterone and flutamide. Malgor LA; Valsecia M; Vergés E; De Markowsky EE Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):99-105. PubMed ID: 9695882 [TBL] [Abstract][Full Text] [Related]
7. Partial prevention of compactin (ML-236B) inhibition of in vitro hematopoiesis by dolichol and dolichyl phosphate. Shimamura M; Urabe A; Takaku F; Mizuno M Exp Hematol; 1986 Sep; 14(8):766-70. PubMed ID: 3743679 [TBL] [Abstract][Full Text] [Related]
8. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells. Bilgeri R; Petzer AL; Zilian U; Geisen FH; Schirmer M; Haun M; Konwalinka G Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026 [TBL] [Abstract][Full Text] [Related]
9. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation. Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448 [TBL] [Abstract][Full Text] [Related]
10. Erythroid progenitor cell numbers in human marrow - implications for regulation. Eaves CJ; Eaves AC Exp Hematol; 1979; 7 Suppl 5():54-64. PubMed ID: 263246 [TBL] [Abstract][Full Text] [Related]
11. Influence in vitro of IL-3/Epo fusion proteins compared with the combination of IL-3 plus Epo in enhancing the proliferation of single isolated erythroid and multipotential progenitor cells from human umbilical cord blood and adult bone marrow. Lu L; Xiao M; Li ZH; Jolliffe LK; Jones S; Broxmeyer HE; Weich N Exp Hematol; 1995 Sep; 23(10):1130-4. PubMed ID: 7656932 [TBL] [Abstract][Full Text] [Related]
12. Effects of human recombinant erythropoietin on differentiation and distribution of erythroid progenitor cells on murine medullary and splenic erythropoiesis during hypoxia and post-hypoxia. Mide SM; Huygens P; Bozzini CE; Fernandez Pol JA In Vivo; 2001; 15(2):125-32. PubMed ID: 11317516 [TBL] [Abstract][Full Text] [Related]
13. Effect of 1,25 dihydroxyvitamin D3 and retinoic acid on normal human pluripotent (CFU-mix), erythroid (BFU-E), and myeloid (CFU-C) progenitor cell growth and differentiation patterns. Nagler A; Riklis I; Kletter Y; Tatarsky I; Fabian I Exp Hematol; 1986 Jan; 14(1):60-5. PubMed ID: 3510890 [TBL] [Abstract][Full Text] [Related]
14. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941 [TBL] [Abstract][Full Text] [Related]
15. Temporal response of murine pluripotent stem cells and myeloid and erythroid progenitor cells to low-dose glucan treatment. Patchen ML; MacVittie TJ Acta Haematol; 1983; 70(5):281-8. PubMed ID: 6414220 [TBL] [Abstract][Full Text] [Related]
16. Effects of dolichol and dolichyl phosphate on in vitro differentiation of hematopoietic progenitors. Shimamura M; Urabe A; Takaku F; Mizuno M Int J Cell Cloning; 1985 Sep; 3(5):313-9. PubMed ID: 4045257 [TBL] [Abstract][Full Text] [Related]
17. Hematopoiesis in the rat: quantitation of hematopoietic progenitors and the response to iron deficiency anemia. Kimura H; Finch CA; Adamson JW J Cell Physiol; 1986 Feb; 126(2):298-306. PubMed ID: 3944211 [TBL] [Abstract][Full Text] [Related]
18. Effects in vivo of recombinant human inhibin on myelopoiesis in mice. Hangoc G; Carow CE; Schwall R; Mason AJ; Broxmeyer HE Exp Hematol; 1992 Nov; 20(10):1243-6. PubMed ID: 1426104 [TBL] [Abstract][Full Text] [Related]
20. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma. Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]